The book is a complete discussion of product development in the pharmaceutical and biotechnology industries from discovery, to product launch, and through life cycle management. Format is optimized for education and training of health care professionals, especially fellows in training (MD, PharmD, PhD), at universities. Format of the book is a set of figures, tables and lists, that can become power-point style slides as well, and the detailed narrative descriptions, including real-life examples, illustrations, controversies in industry, and references. Industry and research experts (multidisciplinary ' MD, PharmD, and PhD) are editors and authors. An added CD-ROM (slides only) enhances utility and marketability of book to course directors, providing the highly sought after slides for lectures.... Saamp;M) Payers for drugs (Insurance aamp; Medicare) Medication safety focus (IOM, Businesses) Costs for health care aamp; drugs FIG. 1.7. Trends (2000+) aamp; R aamp; D Impacts biotechnology is unlocking many secrets of genetics, proteomics, and especially intracellular function, ... for anemia of cancer, beta-interferons [Avonex Ar and RebifAr] for multiple sclerosis, and RemicadeAr and EnbrelAr for rheumatoid arthritis).
|Title||:||Drug and Biological Development|
|Publisher||:||Springer Science & Business Media - 2007-08-14|